Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum Symptom
Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The aim of this study was to assess the effectiveness for small airway inflammation of 4
weeks lysozyme administration in Chronic Obstructive Pulmonary Disease (COPD) and/or asthma.